Survivalism & Self Sufficiency Topics > COVID-19 Coronavirus Pandemic

Coronavirus COVID-19 (a.k.a. 2019-nCoV) outbreak in China

<< < (276/279) > >>


--- Quote from: iam4liberty on August 08, 2020, 09:20:31 AM ---Same for The Lancet published so called "peer reviewed", "gold standard" study.  It took less than five minutes to see the base sizes in the tables didn't add up.  And others pointed out immediately that reported cases in some areas were greater than their population. Yet, this was, according to WHO, the definitive work and all other research on hydroxychloroquine had to be cancelled immediately.  That is as anti-scientific as it gets.

--- End quote ---

Update.  The hyped 'gold standard' study has definitively been ruled fraudulent. Essentially, they just made up the data and shopped it around to some physicians eager to 'Dump on Drumpf".  These physicians never even bothered to look at the data despite the number one responsibility of being a scientist is ensuring data integrity and understanding/reporting its limitations.  Turns out the similarly media vaunted study in the New England journal of Medicine was also made up by them. 

So where are all the newsmedia retractions for their stories that propogated this myth?  Are the 'fact checkers' going to fact check their "fact" checks?  Will all the social media companies unban the people they deplatformed based on these faked pieces of research?  Will the WHO ever apologize for all the misinfo it pushes out to appease its communist leader?
The Lancet changes editorial policy after hydroxychloroquine Covid study retraction
New policy comes after serious quality control questions were raised about the data relied on by a study in the medical journal

Sapan Desai was a co-author of the paper and founder of the Surgisphere database. Following the revelations, information about Surgisphere was deleted from the internet. 

It was also revealed that none of the co-authors of the paper had seen the Surgisphere data for themselves, and they said that Desai did not give them access to it even after questions about the paper were raised by Guardian Australia and the research community. The paper’s co-authors, which included a highly respected vascular surgeon, supported the retraction of the paper and distanced themselves from the data.
World Health Organization studies into hydroxychloroquine resumed following Guardian Australia’s Surgisphere investigation, and the Lancet retracted the Surgipshere paper and vowed to review its publication policy. Such rapid retractions are rare, and followed pressure from the international research community who questioned how the study passed quality control processes.

The new policy, published three months after the study was retracted, requires that more than one author on a paper must directly access and verify the data reported in the manuscript.


--- Quote ---A study by European scientists published Wednesday by the journal Nature examined a cluster of genes that have been linked to a higher risk of hospitalization and respiratory failure in patients who are infected with the new coronavirus.

Researchers Hugo Zeberg and Svante Paabo determined that the genes belong to a group, or haplotype, which likely came from Neanderthals. The haplotype is found in about 16% of the population in Europe and half the population in South Asia, while in Africa and East Asia it is non-existent.

--- End quote ---

To state the obvious:  China is in East Asia with virtually no exposure to the DNA that the higher risks affect.  Other nations that "compete" with China for power (Europe, India, US...) have it.  Suspicious to say the least.


--- Quote from: iam4liberty on July 20, 2020, 09:47:43 AM ---Another low sample size, somewhat limited representative study. (sigh)  But at least this one included zinc in early treatment and confirmed positive COVID patients .  The results are in line with earlier ones demonstrating dramatic efficacy of the combination. A strong meta-analysis case is forming.

--- End quote ---

Meta-analysis of randomized, placebo contolled studies just released.  It shows a substantial benefit to hydroxychloroquine treatment that is statistically significant.  it suggests many thousands of lives could have been saved if treatment option had not been ambushed for political reasons.
Randomized Controlled Trials of Early Ambulatory Hydroxychloroquine in the Prevention of COVID-19 Infection, Hospitalization, and Death: Meta-Analysis

Results--Five randomized controlled clinical trials enrolling 5,577 patients were included. HCQ was associated with a 24% reduction in COVID-19 infection, hospitalization or death, P=.025 (RR, 0.76 [95% CI, 0.59 to 0.97]). No serious adverse cardiac events were reported. The most common side effects were gastrointestinal. Conclusion--Hydroxychloroquine use in outpatients reduces the incidence of the composite outcome of COVID-19 infection, hospitalization, and death. Serious adverse events were not reported and cardiac arrhythmia was rare.

Mr. Bill:
Reuters: Trump 'doing very well' in hospital after COVID-19 diagnosis, doctor says

--- Quote ---...White House doctor Sean P. Conley ... said Trump had received a first dose of a five-day course of Remdesivir, an intravenous antiviral drug sold by Gilead Sciences Inc that has been shown to shorten hospital stays. He is also taking an experimental treatment, Regeneron’s REGN-COV2, one of several experimental COVID-19 drugs known as monoclonal antibodies, as well as zinc, Vitamin D, famotidine, melatonin and aspirin, Conley has said. ...
--- End quote ---

But no hydroxychloroquine.


--- Quote from: Mr. Bill on October 03, 2020, 11:14:49 AM ---Reuters: Trump 'doing very well' in hospital after COVID-19 diagnosis, doctor says

But no hydroxychloroquine.

--- End quote ---

I noticed that, too. I wonder if we will hear more about this question as time goes on...


[0] Message Index

[#] Next page

[*] Previous page

Go to full version